|
業務類別
|
Biotechnology |
|
業務概覽
|
Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers. |
| 公司地址
| c/o BeOne Medicines I GmbH, 94 Aeschengraben 27, 21st Floor, Basel, CHE, 4051 |
| 電話號碼
| +41 616851900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.beonemedicines.com |
| 員工數量
| 12000 |
| Mr. Aaron Rosenberg |
Chief Financial officer |
美元 660.00K |
28/04/2026 |
| Mr. Chan Henry Lee |
Senior Vice President, General Counsel and Corporate Secretary |
美元 654.00K |
28/04/2026 |
| Dr. Xiaobin Wu, PhD |
President and Chief Operating Officer |
美元 862.41K |
28/04/2026 |
| Mr. Titus B. Ball |
Principal Accounting Officer |
-- |
26/02/2026 |
| Dr. Lai Wang, PhD |
President, Global Head of Research and Development |
美元 659.49K |
28/04/2026 |
| Mr. John V. Oyler |
Chief Executive Officer and Chairman of the Board |
美元 1.13M |
28/04/2026 |
|
|
| Mr. Anthony C. Hooper |
Independent Director |
28/04/2026 |
| Mr. Ranjeev Krishana |
Lead Independent Director |
28/04/2026 |
| Mr. Qingqing Yi |
Independent Director |
28/04/2026 |
| Dr. Corazon Dating Sanders, PhD |
Independent Director |
28/04/2026 |
| Dr. Xiaodong Wang, PhD |
Director |
28/04/2026 |
| Mr. John V. Oyler |
Chief Executive Officer and Chairman of the Board |
28/04/2026 |
| Mr. Michael J. Goller |
Independent Director |
28/04/2026 |
| Dr. Olivier Raymond Brandicourt, M.D. |
Independent Director |
28/04/2026 |
| Ms. Shalini Sharp, M.B.A. |
Independent Director |
28/04/2026 |
| Dr. Alessandro Riva, M.D. |
Independent Director |
28/04/2026 |
| Dr. Margaret Dugan, M.D. |
Independent Director |
28/04/2026 |
|
|
|
|
